Sleep Apnea Diagnostics and Therapeutic Devices Market to Gain Edge Due to Well-equipped Healthcare Infrastructures in Developed Economies

Sleep apnea, a common sleep-related disorder characterized by a temporary and frequent interruption or pauses in breathing during sleep, continues to levy a huge economic burden on countries owing to high cost of sleep apnea diagnosis and therapy as well as the loss of productivity of patients with the condition. In the U.S. alone, with a patient base of more than 20 mn adults, the cost of management of the condition is around US$65 bn to US$165 bn every year. This is significantly higher than the cost of managing diseases such as hypertension, heart failure, and asthma, which fall in the range of US$20 bn–US$80 bn every year in the country.

In other parts of the world as well, the condition is rapidly gaining the attention of the respective healthcare fraternities and the demand for effective sleep apnea therapeutics and diagnostics devices is on a constant rise. In the near future, the rise in awareness regarding the severity of the condition, in the way it could lead to health conditions such as mood and memory issues, heart diseases, and hypertension, is expected to boost the global demand for effective sleep apnea diagnostic and therapeutic devices.

Transparency Market Research estimates that the market will register growth at a healthy pace in the next few years and rise from a valuation of US$5,138.9 mn in 2016 to US$6,437.6 mn in 2019.

Get Sample Reports:

In this blog post, TMR analysts highlight some of the key aspects of the global sleep apnea diagnostics and therapeutic devices market: 

Which strategies adopted by the leading players are likely to accelerate growth?

The market for sleep apnea devices is highly competitive owing to the dominance of few large players, which compete on the fronts of product features and cost. To stay ahead of the competition and strengthen their relationship with buyers, leading players are often seen to enter into long-term supply and post-purchase service contracts with key end-users such as diagnostic laboratories and hospitals. Leading vendors are also focused on extensive research and development activities to be able to cater effectively to the specific demands and needs of consumers and maintain a good level of product differentiation and technological sophistication in deliverables.

However, the market still offers excellent growth opportunities to new vendors in terms of the unmet needs in the field of devices that can offer online or real time monitoring of patient data and minimally invasive surgical techniques. Demand for Portable, easy-to-use, and convenient sleep apnea devices is also high in the global market, providing vast growth opportunities to companies already in the market or the ones wanting to venture into the area.

Why is the market expected to witness better growth avenues in developed economies compared to in developing economies?

Developed economies across regions such as North America and Europe lead in terms of the overall demand and expenditure for a variety of sleep apnea devices. The large patient pools, affluent consumer base, and a high level of awareness regarding the variety of highly effective diagnostic and treatment options for sleep apnea available in the market are the key factors making these regions the most attractive investment grounds for the sleep apnea devices market. These regions are also considered lucrative for the sleep apnea devices market owing to the favorable medical reimbursement scenario and the presence of several well-equipped sleep testing laboratories.

On the other hand, developing economies across regions such as Asia Pacific and Middle East and Africa exhibit slow growth prospects for the sleep apnea devices market. The chief factor leading to this scenario is the lack of awareness regarding the condition and its serious implications on human health and everyday life and the lack of technical expertise related to chronic sleep disorders. Moreover, unfavorable reimbursement scenario and ill-equipped healthcare infrastructures further restrict the growth prospects of the market in these regions.

Geriatric Population Considered as Target Consumers by Ophthalmology Devices Manufacturers

As elderly population are more prone to develop eye-related disorders, they are considered the target customers for ophthalmology device manufacturers. In the next few years, the global ophthalmology devices segment is expected to witness robust growth in the medical device segment. The market is also expected to gain from the launch of new devices by the newer market players. Despite witnessing an overall positive growth, the high cost of these devices is projected to emerge as the key restraint. Nevertheless, the rapid pace of the increase in the aging population, the rising focus on healthcare, and technological advancements in ophthalmology devices will continue propelling the market’s growth in the forthcoming years. 

Spurred by the aforementioned factors, the global ophthalmology devices market is forecast to exhibit a CAGR of 5.10% CAGR between 2012 and 2018. At this pace, the market is projected to reach US$18.28 bn by the end of 2018 from a valuation of US$12.92 bn in 2012. 

Get Sample Report:

Q: Which factors will create lucrative opportunities for the global ophthalmology devices market? 

A: Medical devices in the ophthalmology segment are used for myriad purposes such as vision care, diagnosis, and surgery. Innovations of orphan products and novel application of the technology have provided consumers with economical and viable solutions for the treatment of various eye related disorders. For instance, Tecnis Symfony® IOL, a product of Abbott Medical Optics, Inc. has been recently approved by the U.S. Food and Drug Administration as the first “extended depth of focus” to be found in the U.S. market. The IOL is touted by many as a game changer in the ophthalmology devices market. 

Currently, a large share in the global ophthalmology devices market is held by the vision care devices segment on account of the end user base. The rising demand for contact lens, disinfecting solutions, lens cleaning, spectacles, and other devices for the diagnosis of eye disorder or during surgery in hospitals and by ophthalmologists is expected to provide significant impetus to the global ophthalmology devices market. 

Q: Which regional markets will help the global ophthalmology devices market rake high gains? 

A: Some of the key markets for ophthalmology devices are Canada, Italy, Germany, Spain, India, China, Brazil, Japan, France, Mexico, the U.S., and the U.K. Among these, the U.S. has emerged dominant in the global ophthalmology devices market, trailed by the U.K. Western markets such as the U.K., and the U.S. are witnessing a high degree of competition due to the concentration of the leading market players in these countries. Besides this, the market will also witness immense opportunities in developing economies as manufacturers shift their focus towards capitalizing on the opportunities prevalent therein. 

Some of the key players operating in the global ophthalmology devices market are Johnson and Johnson Vision Care, Essilor International, Canon Inc., Alcon Inc., CooperVision AG, Hoya Corporation, Bausch and Lomb Inc., Abott Medical Optics Inc., Carl Zeiss AG, Nidek Co Ltd., and Topcon Corporation.

Europe Heparin Market Finds Connection with Soaring Geriatric Population having VTE Diseases

The Europe heparin market is projected to flaunt a solid growth, now many years from now, owing to the unreasonable ubiquity of coagulation diseases in the region and its developed economy. Since age holds a direct correlation with venous thromboembolism (VTE) diseases such as deep vein thrombosis (DVT) and pulmonary embolism (PE), the rising geriatric population in Europe is anticipated to propel the advancement of the heparin market in the region.

Nonetheless, Europe is a significant geographical segment by itself that majorly contributes toward the burgeoning of the global heparin market. As per the figures shared by the European Commission’s Ageing Report in 2015, the population above the age of 65 years is foreseen to expand from 21.0% in 2013 to 32.0% in 2060.

A leading market research firm, Transparency Market Research (TMR), has announced the expansion of the Europe heparin market at a CAGR of 5.2% between 2016 and 2024 to touch US$3.5 bn by the later year. In 2015, the market had attained the value of US$2.2 bn.

Get Sample Report:

Which are the Prominent European Nations Likely to make a Statement?

In the future scenario and according to the historical analysis of the Europe heparin market, Germany and France are predicted to outshine the other top countries in the region. With a colossal market share in 2015, Germany is envisaged to hold the ruling position in the Europe market until the end of the forecast period. New heparin processors and manufacturers are reckoned to enter the market on the back of stiff government mandates to eliminate adulteration in the Chinese active pharmaceutical ingredients (APIs).

Howbeit, the demand for heparin has augmented considerably in Germany due to the mushrooming occurrence of VTE diseases. Stringent policies concerning the import of heparin have enforced Germany-based firms to acquire heparin API manufacturers.

France stands second on the basis of market growth and is trailed by Belgium, Portugal, Italy, Spain, and the U.K. However, France is estimated to secure a herculean growth in the foreseeable future while riding on higher consumption of heparin during and post the common surgical procedures such as breast, knee replacement, appendectomy, and hip surgeries.

Other European nations such as Poland, Switzerland, Austria, Hungary, the Czech Republic, Greece, and Slovakia and the Rest of Europe are also expected to stay in the race.

How will the Europe Heparin Market Fare in Top Segments?

While the blood and stem cell banks segment exhibited significant growth in the base year of the forecast period, the Europe heparin market had its turning point with the extensive application in hospitals. Since most surgical procedures are conducted in hospitals, the segment has remarkably dominated the market. Calcilean, calciparine, heparin-leo, hepalean-lok, and hepalean are some of the frequently used heparins in a hospital setting. In clinics and hospitals, heparin is voluminously used as a blood thinner during the treatment of orthopedic, cancer, and cardiovascular diseases.

Few of the key players, viz. Pfizer, Inc., Dr. Reddy’s Laboratories, Sanofi SA, Leo Pharma, and Teva Pharmaceutical Industries Ltd., are prophesied to grab the attention in the Europe heparin market.

Steady Advancement of Active Pharmaceutical Ingredient Market Due to High Incidence of Chronic Diseases

Active pharmaceutical ingredients (APIs) are generally known as ‘bulk pharmaceuticals’. According to the findings of Transparency Market Research, the revenue from the active pharmaceutical ingredient market will rise to US$219.60 bn in 2023, which in 2015 was US$134.7 bn. A promising CAGR of 6.3% is expected between the years 2015 and 2023. According to type, the market can be classified into generic and innovative API. 

Teva Pharmaceutical Industries Ltd., Dr.Reddy’s Laboratories Limited, Zhejiang Medicine Co., Ltd., North China Pharmaceutical Group Corp. (NCPC), Zhejiang Hisun Pharmaceutical Co., Ltd., Sandoz (Novartis AG), Aurobindo Pharma Limited, Zhejiang NHU Co., Ltd, Northeast Pharmaceutical Group Co., Ltd., and Zhejiang Huahai Pharmaceuticals Co., Ltd. are a few of the major players in the market.


What are the key drivers and restraints in the active pharmaceutical ingredient market? 

The development of geriatrics, a branch of medicine dealing with health and care of the aged population, has contributed significantly to the thriving API market worldwide. Growing awareness about medications and access to healthcare facilities, together with technological advancements, has led to a greater demand for drugs. The API market has gained considerable impetus from these developments. 

Emerging economies have been witnessing a rising demand for drugs that use active pharmaceutical ingredients. The rising prevalence of neurological disorders, cardiovascular diseases, diabetes, and other metabolic disorders and diseases has made the manufacturing of the aforementioned drugs imperative. In 2015, these diseases held around 50% share in the worldwide market. A CAGR of 6.63% is projected between 2015 and 2023. The patent loss of several popular drugs between 2011 and 2015 has further opened up the doors for a flourishing API market.

The healthcare budget in developing countries has increased, contributing towards the expansion of the API market. Moreover, the conformity of some API-manufacturing Indian industries with U.S. FDA norms has further propelled the API market. The expansion of the biotechnology sector in Asia Pacific is expected to be a key driver in the market for APIs.

The key restraints in the API market include increasing competition, the implementation of stringent regulatory rules and high manufacturing costs.

Which are the geographical segments dominating the scene in the API market?

In 2014, North America claimed a share of 35.1% in the overall API market. The dominance of North America is on account of large pharmaceutical companies that present a greater demand for active pharmaceutical ingredients. It has been expected that the introduction of biosimilars in the market will further prove to be beneficial for the expansion of the API market in North America.

According to the findings of TMR, Asia Pacific will emerge as a leader in the API market. The API market in emerging economies such as India, Japan, South Korea, and China will gain impetus over the coming years.  

Experts within the industry find that Asia Pacific is the second-leading geographical segment in terms of revenue generated. Although presently India and China are leading the API market in Asia, countries such as Indonesia, Philippines, Vietnam, and Malaysia possess rapidly expanding API markets. 

General Medicine Education Publishing Market to Gain from Popularity of Online Education

The global general medicine education publishing market has been steadily advancing due to the expansion of several associated markets. The necessity of primary healthcare, the growing online education industry, and the popularity of eBooks are a few of the key drivers of the global general medicine education publishing market. The major restraints include decreasing enrolments of students into the medical stream owing to higher fees, the unavailability of modern technology in emerging countries, and macroeconomic policies associated with reimbursements.

Also known as “internal medicine”, general medicine deals with the diagnosis, prevention and treatment of diseases. Internists, physicians who practice general medicine, are capable of dealing with all kinds of problems that a patient brings- whether simple or complicated. Chronic illnesses and incidence of several diseases simultaneously attacking a patient are some of the situations internists excel at. Some of the internists are known as “hospitalists”, as they are concerned providing care to the patients. More number of students have been opting to study medicine, and this has proved to be beneficial to the general medicine education publishing market. 


The leading companies in this field are Wolters Kluwer, Springer Books, Reed Elsevier, McGraw-Hill, John Wiley & Sons Inc., and Kaplan. 

Q.  How has online education affected the general medicine education publishing market?

The growth of the online education market has led to the expansion of the general medicineeducation publishing market in recent times. By the end of 2015, the online education industry was pegged at US$100 bn in terms of revenue. This boom in the online education industry has directly affected the general medicine education publishing market since a number of organizations and institutes are using the Internet as a tool for providing distance learning to students.

The global general medicine education publishing market is expected to rise gradually to US$2.4 bn by 2018. Presently, North America leads the market and will continue to do so till 2018, when it is projected to hold 51.9% of the total market for global general medicine education publishing.

The expansion of custom content publishing market and the incidence of illnesses caused by lifestyle factors will also benefit the general medicine education publishing market over the coming years. 

Q. What are the key segments of the global medicine education publishing market?

In broad terms, the global general medicine education publishing market is divided on the basis of two parameters: one criteria is type of publishing and the other is region.  

On the basis of online and electronic publishing, the key segments are digital and electronic reference books and textbooks, hospital training, multimedia content, distance learning, online reference tools and mobile applications. In the print segment, custom content publishing, print reference books and textbooks, hospital training, distance learning, and testing and self-assessment are the major segments in the market. 

The custom content publishing segment is expected to dominate with a 57% share in the market by the end of 2018. While the custom content publishing segment leads the market, online reference tools such as WebMD and Micromedex are the second leading segment, followed by eBooks, printed reference books, and textbooks. Since the custom content publishing market is highly-priced, it will continue to lead the market in terms of revenue, experts opine.

According to geography, the market for general medicine education publishing is categorized into Asia, North America, Europe, and Rest of the World.

Governmental Push to Improve Efficiency Favoring Global Energy Saving and Performance Contracting Market

Energy savings and performance contracting (ESPC) refers to a neutral approach to reduce energy consumption and water use of a building, and thereby increase the overall operational efficiency. Facilities owners can now preserve their capital budgets by collaborating with energy service company (ESCO) and pay for the upgrades in installments while the energy saving continues. In some cases, the ESCO implement a renewable energy project to the facilities, which have higher return values, although heavy initial investment hesitates the consumers. In the recent past, several local and state governments have implemented ESPC projects in their facilities, and encourage these projects for its long term benefits. However, unless the project delivers energy savings as anticipated, the ESCO are not compensated. According to a recent report by Transparency Market Research (TMR), the global market for energy saving and performance contracting will expand at a healthy growth rate during the forecast period of 2016 to 2024.

What are the factors influencing the growth rate?

Owing to the growing energy requirement across the world, oil and gas industry is thriving, and the TMR report anticipates this factor to reflect on global energy saving and performance contracting market. During the forecast period, several governments are expected to loosen the restrictions on the electricity and gas industry players to fulfill the escalating energy demand. Increased investments by several private and public sector industries on eco-friendly systems is another factor favoring the market, although the lack of information pertaining to the energy efficiency possible from ESPC is expected to curtail the expansion over the course of the forecast period. The lack of commercially feasible project financing within the backing sector across several developing economies is also seen as a restraint over the market.


Which market segments are expected to gain momentum in near future?

The global energy saving and performance contracting market can be segmented on the basis of technology, and business contract model. By technology, the market is divided into combined heat and power (CHP), district heating (DH) refurbishment, and fuel switch, heating, ventilation, and air conditioning (HVAC), renewable energy sources (RES) utilization, lighting, and others including gas distribution, compressed air, reactive power, process unit, and combustion improvement. The report picks out combined heat and power segment as the most lucrative segment in the present global scenario.

By business contract models, the market is segmented into shared savings contracting model, guaranteed savings contracting model, and others. Since ESPC projects are dependent on various factors, guaranteed savings model sometimes result losses for the investors and hence, the segment of shared saving model is most in demand. In this, energy saving and performance contracting is designed, financed, implemented, and verified for over a fixed period to ensure the savings to the customer. In some cases, the energy service company may receive finances from a third party directly.

Longevity and Operational Efficiency of Consumer Electronics to Provide Thrust to Global Smart Coating Market

Smart coatings are the futuristic coating. The smart functional coatings market is expected to leap from a niche market due to the increasing demand of customers for improved products. Some functional smart coatings that are evolving are antimicrobial, wear-resistant, easy-to-clean, scratch, and anti-fouling coatings. Regardless of their new developmental status, smart coatings have a broad range of applications. 

Smart coatings have the capability to sense a change in the external environmental and respond to that change in a predictable and notable manner. Smart coatings integrate functionality with design to provide a system that offers multidimensional and multifunctional effects simultaneously.

Analysts at Transparency Market Research provide insights into the growth of the global smart coating market for the 2016-2024 period:

Q. What are the key factors propelling the growth of the smart coating market?

A. In recent years, the expeditiously rising consumer electronics industry is leading to an increased demand for smart coatings. For smartphones and other handheld electronics, self-cleaning coatings and self-healing coatings are of paramount importance. Extensive efforts for the research and development of smart coatings has led to the development of newer smart coating products.

The unique characteristics of smart coating is leading to its gaining popularity in military, aerospace, hospital, and automobiles industry. Multilayer coatings are considered as the easiest way to develop multifunctional coatings. Moreover, novel materials such as metamaterials are increasingly being used for the development of innovative smart coatings. These factors collectively are favoring the growth of the global smart coating market.


Q. What are the factors deterring the ascension of the smart coating market?

A. Smart coating market is a relatively new area in the global coating market space. High cost and environmental implications of smart coating are the foremost factors that are negatively impacting the growth of the smart coating market. Presently, the green quotient of materials is very important along with quality, consistency, and superiority. The cost factor of bio-based materials is advantageous to the bargaining power of leading suppliers and is restricting the entry of new players in the smart coating market.

Q. How are the regional markets for smart coating expected to fare in the coming years?

A. The North America smart coatings market is expected to ride on technological advancements in the development of nanomaterials. The incessantly increasing demand for environment-friendly products will also boost the growth of the smart coatings market in this region.

Asia Pacific will emerge as a significant market for smart coatings. This is mainly due to the rapid rate of infrastructural development, growth in the construction sector, and an ever-increasing demand for consumer electronics in the region. Some of the upcoming events such as the FIFA world cup in Qatar in 2022 and world expo trade convention in Dubai in 2020 will proliferate the growth of the smart coatings market in Asia Pacific.

Latest Post

Market Research Reports